Ilaria Caputo, Giovanni Bertoldi, Giulia Driussi, Luca Sgarabotto, Gianni Carraro, Lucia Federica Stefanelli, Paul A Davis, Lorenzo A Calò
No abstract text is available yet for this article.
May 25, 2023: Journal of Internal Medicine
Bianca Tesi, Catherine Boileau, Kym M Boycott, Guillaume Canaud, Mark Caulfield, Daniela Choukair, Sue Hill, Malte Spielmann, Anna Wedell, Valtteri Wirta, Ann Nordgren, Anna Lindstrand
Molecular diagnostics is a cornerstone of modern precision medicine, broadly understood as tailoring an individual's treatment, follow-up, and care based on molecular data. In rare diseases (RDs), molecular diagnoses reveal valuable information about the cause of symptoms, disease progression, familial risk, and in certain cases, unlock access to targeted therapies. Due to decreasing DNA sequencing costs, genome sequencing (GS) is emerging as the primary method for precision diagnostics in RDs. Several ongoing European initiatives for precision medicine have chosen GS as their method of choice...
May 21, 2023: Journal of Internal Medicine
Haoran Wei, Junfang Wu, Huiqing Wang, Jin Huang, Chenze Li, Yuxuan Zhang, Yaonan Song, Zhitong Zhou, Yang Sun, Lei Xiao, Liyuan Peng, Chen Chen, Chunxia Zhao, Dao Wen Wang
BACKGROUND: Phenylacetylglutamine (PAGln)-a newly discovered microbial metabolite produced by phenylalanine metabolism-is reportedly associated with cardiovascular events via adrenergic receptors. Nonetheless, its association with cardiovascular outcomes in heart failure (HF) patients remains unknown. OBJECTIVES: This study aimed to prospectively investigate the prognostic value of PAGln for HF. METHODS: Plasma PAGln levels were quantified by liquid chromatography-tandem mass spectrometry...
May 15, 2023: Journal of Internal Medicine
Artur Fedorowski, Monika Fagevik Olsén, Frida Nikesjö, Christer Janson, Judith Bruchfeld, Maria Lerm, Kristofer Hedman
A significant proportion of COVID-19 patients experience debilitating symptoms for months after the acute infection. According to recent estimates, approximately one out of ten COVID-19 convalescents reports persistent health issues more than three months after initial recovery. This "post-COVID-19 condition" may include a large variety of symptoms from almost all domains and organs, and for some patients it may mean prolonged sick-leave, homestay, and strongly limited activities of daily life. In this narrative review, we focus on the symptoms and signs of post-COVID-19 condition in adults-particularly those associated with cardiovascular and respiratory systems, such as postural orthostatic tachycardia syndrome (POTS) or airway disorders-and explore the evidence for chronic autonomic dysfunction as a potential underlying mechanism...
May 14, 2023: Journal of Internal Medicine
Albert Parés, Núria Guañabens
No abstract text is available yet for this article.
May 10, 2023: Journal of Internal Medicine
Francesca De Vito, Velia Cassano, Elettra Mancuso, Elena Succurro, Marta Letizia Hribal, Angela Sciacqua, Francesco Andreozzi, Giorgio Sesti, Teresa Vanessa Fiorentino
BACKGROUND: Neurotensin (NT), an intestinal peptide able to promote fat absorption, is implicated in the pathogenesis of obesity. Increased levels of proneurotensin (pro-NT), a stable NT precursor fragment, have been found in subjects with nonalcoholic fatty liver disease (NAFLD); however, whether higher pro-NT levels are associated with an increased NAFLD risk independently of other metabolic risk factors is unsettled. METHODS: Ultrasound-defined presence of NAFLD was assessed on 303 subjects stratified into tertiles according to fasting pro-NT levels...
May 8, 2023: Journal of Internal Medicine
Maribel Aranda-Guillén, Ellen Christine Røyrvik, Sara Fletcher-Sandersjöö, Haydee Artaza, Ileana Ruxandra Botusan, Marianne A Grytaas, Åsa Hallgren, Lars Breivik, Maria Pettersson, Anders P Jørgensen, Anna Lindstrand, Elinor Vogt, Eystein S Husebye, Olle Kämpe, Anette S Bøe Wolff, Sophie Bensing, Stefan Johansson, Daniel Eriksson
BACKGROUND: Autoimmune Addison's disease (AAD) is the most common cause of primary adrenal insufficiency (PAI). Despite its exceptionally high heritability, tools to estimate disease susceptibility in individual patients are lacking. We hypothesized that a polygenic risk score (PRS) for AAD could help investigate PAI pathogenesis in pediatric patients. METHODS: We here constructed and evaluated a PRS for AAD in 1223 seropositive cases and 4097 controls. To test its clinical utility, we reevaluated 18 pediatric patients, whose whole genome we also sequenced...
May 8, 2023: Journal of Internal Medicine
Joël L Gerber, Anna S Messmer, Tobias Krebs, Martin Müller, Debora M Hofer, Carmen A Pfortmueller
PURPOSE: To systematically assess test performance of patient-adapted D-dimer cut-offs for the diagnosis of venous thromboembolism (VTE). METHODS: Systematic review and analysis of articles published in PubMed, Embase,, and Cochrane Library databases. Investigations assessing patient-adjusted D-dimer thresholds for the exclusion of VTE were included. A hierarchical summary receiver operating characteristic model was used to assess diagnostic accuracy...
May 4, 2023: Journal of Internal Medicine
Åke Lernmark, Beena Akolkar, William Hagopian, Jeffrey Krischer, Richard McIndoe, Marian Rewers, Jorma Toppari, Kendra Vehik, Anette-G Ziegler
The etiology of type 1 diabetes foreshadows the pancreatic islet beta-cell autoimmune pathogenesis that heralds the clinical onset of type 1 diabetes. Standardized and harmonized tests of autoantibodies against insulin (IAA), glutamic acid decarboxylase (GADA), islet antigen-2 (IA-2A) and ZnT8 transporter (ZnT8A) allowed children to be followed from birth until the appearance of a first islet autoantibody. In the Environmental Determinants of Diabetes in the Young (TEDDY) study, a multicenter (Finland, Germany, Sweden and the US) observational study, children were identified at birth for the type 1 diabetes high risk HLA haplogenotypes DQ2/DQ8, DQ2/DQ2, DQ8/DQ8 and DQ4/DQ8...
May 4, 2023: Journal of Internal Medicine
Yimin Zhao, Yueying Li, Wenxiu Wang, Zimin Song, Zhenhuang Zhuang, Duo Li, Lu Qi, Tao Huang
BACKGROUND: Short-term clinical trials have shown the effectiveness of low-carbohydrate diets (LCDs) and low-fat diets (LFDs) for weight loss and cardiovascular benefits. We aimed to study the long-term associations among LCDs, LFDs, and mortality among middle-aged and older people. METHODS: This study included 371,159 eligible participants aged 50-71 years. Overall, healthy and unhealthy LCD and LFD scores, as indicators of adherence to each dietary pattern, were calculated based on the energy intake of carbohydrates, fat, and protein and their subtypes...
May 3, 2023: Journal of Internal Medicine
Carl-Gustaf Elinder
No abstract text is available yet for this article.
May 1, 2023: Journal of Internal Medicine
Alexander Liu, Robert Hammond, Peter D Donnelly, Juan Carlos Kaski, Anthony Rm Coates
In acute COVID-19 patients, effective clinical risk stratification has important implications on treatment and therapeutic resource distribution. This article reviews the evidence behind a wide range of biomarkers with prognostic value in COVID-19. Patient characteristics and co-morbidities, such as cardiovascular and respiratory diseases, are associated with increased mortality risk. Peripheral oxygen saturation and arterial oxygenation are predictive of severe respiratory compromise, whilst risk scores such as the 4C-Score enable multi-factorial prognostic risk estimation...
April 27, 2023: Journal of Internal Medicine
Xinyuan He, Fan Lv, Marissa Fox, Yee Hui Yeo, Biyao Zou, Jinli Liu, Yunyu Zhao, Jian Zu, Yan Li, Weiming Tang, Lei Zhang, Fanpu Ji
BACKGROUND: US progress towards ending the HIV epidemic was disrupted during the COVID-19 pandemic. OBJECTIVES: To determine the impact of the pandemic on HIV-related mortality and potential disparities. METHODS: Using data from the Centers for Disease Control and Prevention and the US Census Bureau, HIV-related mortality data of decedents aged ≥25 years between 2012-2021 were analyzed. Excess HIV-related mortality rates were estimated by determining the difference between observed and projected mortality rates during the pandemic...
April 24, 2023: Journal of Internal Medicine
Åsa Johansson, Ole A Andreassen, Søren Brunak, Paul W Franks, Harald Hedman, Ruth J F Loos, Benjamin Meder, Erik Melén, Craig E Wheelock, Bo Jacobsson
Complex diseases are caused by a combination of genetic, lifestyle, and environmental factors and comprise common noncommunicable diseases, including allergies, cardiovascular disease, and psychiatric and metabolic disorders. More than 25% of Europeans suffer from a complex disease, and together these diseases account for 70% of all deaths. The use of genomic, molecular, or imaging data to develop accurate diagnostic tools for treatment recommendations and preventive strategies, and for disease prognosis and prediction, is an important step toward precision medicine...
April 24, 2023: Journal of Internal Medicine
Kyoung Jin Kim, Jimi Choi, Kyeong Jin Kim, Nam Hoon Kim, Sin Gon Kim
BACKGROUND: Current evidence regarding the mortality outcomes associated with calcium supplementation with or without low dose vitamin D is conflicting. OBJECTIVES: To investigate the effects of calcium supplementation with or without vitamin D on all-cause and cause-specific mortalities in a large-scale cohort. METHODS: This study used data from the Korean National Health Insurance System database and National Death Registry. A total of 27,846 participants aged >55 years who had taken calcium supplements with or without vitamin D for at least 90 days (calcium supplementation only [CaO], n = 6,256; calcium supplementation in combination with vitamin D [CaD], n = 21,590) were matched in a 1:1 ratio to those who did not take calcium or vitamin D supplements (control group) using propensity scores...
April 13, 2023: Journal of Internal Medicine
Rosario Menéndez, Raúl Méndez, Ana Latorre, Paula González-Jiménez, Germán Peces-Barba, María Molina, Pedro Pablo España, Estela García, Angélica Consuegra-Vanegas, Ana Pando-Sandoval, Carolina Panadero, Juan Marco Figueira-Gonçalves, David De la Rosa, Oriol Sibila, María Dolores Martínez-Pitarch, Nuria Toledo, Pilar Cejudo, Wanda Almonte-Batista, Abigail Macías-Paredes, Diana Badenes, Eli Nancy Pérez-Rodas, Javier Lázaro, Sarai Quirós, Rosa Cordovilla, Irene Cano-Pumarega, Antoni Torres
INTRODUCTION: After severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia, patients may show lung sequelae on radiology and functional impairment at the 1-year follow-up. We aimed to describe the persistence of symptoms, radiological alterations, or reduced diffusing capacity of the lung for carbon monoxide (DLCO ) at 1-year follow-up in patients from the Spanish Registry RECOVID. METHODS: RECOVID collected symptom and radiological and functional lung tests data on hospitalised patients with coronavirus disease 2019 during the acute phase and at the 6- and 12-month follow-up visits...
April 10, 2023: Journal of Internal Medicine
J W So, Fatma Bouibede, Annie-Pierre Jonville-Béra, François Maillot, François Barbier, Bérenger Largeau
BACKGROUND: Although a few case reports have shown that immune checkpoint inhibitors (ICIs) are potential inducers of capillary leak syndrome (CLS), an incidental finding cannot be ruled out. out. The aim of this study was to describe the clinical characteristics of ICI-induced CLS through a systematic review and to assess a potential safety signal. METHODS: Medline/PubMed, Embase and Reactions Weekly were screened and a global disproportionality study was performed using the WHO pharmacovigilance database through January 15, 2023...
April 10, 2023: Journal of Internal Medicine
Cecilie Bo Hansen, Kristina Dvoncova, Laura Pérez-Alós, Kamille Fogh, Johannes Roth Madsen, Caroline Hartwell Garred, Ida Jarlhelt, Pernille Brok Nielsen, Steffan Svejgaard Petersen, Charlotte Gandsø Fjordager, Klara Tølbøll Lauritsen, Linda Hilsted, Lasse Boding, Kasper Karmark Iversen, Liselotte Hyveled, Peter Garred
Factors influencing SARS-CoV-2 antibody dynamics, transmission, waning and long COVID-19 symptomatology are still not fully understood. In the Danish section of the Novo Nordisk Group, we performed a prospective seroepidemiological study during the first and second waves of the COVID-19 pandemic. All employees and their household members (>18 years) were invited to participate in a baseline (June-August 2020), 6-month follow-up (December 2020-January 2021), and 12-month follow-up (August 2021) sampling. In total, 18,614 accepted and provided at least one blood sample and completed a questionnaire regarding socioeconomic background, health status, previous SARS-CoV-2 infection, and persistent symptoms...
April 6, 2023: Journal of Internal Medicine
Binu V John, Dustin Bastaich, Gwilym Webb, Teresa Brevini, Andrew Moon, Raphaella D Ferreira, Allison M Chin, David E Kaplan, Tamar H Taddei, Marina Serper, Nadim Mahmud, Yangyang Deng, Hann-Hsiang Chao, Fotios Sampaziotis, Bassam Dahman
BACKGROUND AND AIMS: Studies have demonstrated that reducing farnesoid X receptor activity with ursodeoxycholic acid (UDCA) downregulates angiotensin-converting enzyme in human lung, intestinal and cholangiocytes organoids in vitro, in human lungs and livers perfused ex situ, reducing internalization of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) into the host cell. This offers a potential novel target against coronavirus disease 2019 (COVID-19). The objective of our study was to compare the association between UDCA exposure and SARS-CoV-2 infection, as well as varying severities of COVID-19, in a large national cohort of participants with cirrhosis...
April 5, 2023: Journal of Internal Medicine
Rosa M M Gynthersen, Christen Rune Stensvold, Signe Ledou Nielsen, Holger Jon Møller, Henrik Vedel Nielsen, Anne-Mette Lebech, Jeppe Romme Christensen, Helene Mens, Daniel El Fassi
BACKGROUND:  Neoehrlichia mikurensis (N. mikurensis) is a newly discovered tick-borne pathogen that can inflict life-threatening illness in immunocompromised patients. N. mikurensis infection is only detectable by polymerase chain reaction (PCR)-based methodologies. We describe three distinct clinical manifestations of N. mikurensis infection (neoehrlichiosis) in Danish patients receiving B-lymphocyte-depleting therapy, rituximab, for underlying hematological, rheumatological, or neurological disorders...
April 3, 2023: Journal of Internal Medicine
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read

Save your favorite articles in one place with a free QxMD account.


Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.